USD
$0.00
(0.00%
)At Close (As of Aug 15, 2025)
$1.63M
Market Cap
-
P/E Ratio
-0.91
EPS
$1.15
52 Week High
$0.00
52 Week Low
REAL ESTATE & CONSTRUCTION
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$3.8M |
Selling General And Administrative | $3.8M |
Research And Development | $26K |
Operating Expenses | $3.8M |
Investment Income Net | - |
Net Interest Income | -$2M |
Interest Income | - |
Interest Expense | $2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$3.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.5M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | - |
Net Income | -$3.3M |
Field | Value (USD) |
---|---|
Total Assets | $902K |
Total Current Assets | $812K |
Cash And Cash Equivalents At Carrying Value | $0 |
Cash And Short Term Investments | $0 |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $90K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $90K |
Short Term Investments | - |
Other Current Assets | $812K |
Other Non Current Assets | - |
Total Liabilities | $99M |
Total Current Liabilities | $34M |
Current Accounts Payable | $799K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $16M |
Total Non Current Liabilities | $65M |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | $16M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $16M |
Other Current Liabilities | $17M |
Other Non Current Liabilities | $5.6M |
Total Shareholder Equity | -$98M |
Treasury Stock | - |
Retained Earnings | -$206M |
Common Stock | - |
Common Stock Shares Outstanding | $28M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$4.2M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | - |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $3.4M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$9.5M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$3.8M |
Selling General And Administrative | $3.8M |
Research And Development | $26K |
Operating Expenses | $3.8M |
Investment Income Net | - |
Net Interest Income | -$2M |
Interest Income | - |
Interest Expense | $2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$3.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.5M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | - |
Net Income | -$3.3M |
Sector: REAL ESTATE & CONSTRUCTION
Industry: BLANK CHECKS
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation.